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Eating behavior may be aﬀected by dopamine synthesis capacity. In this study, 6-[18F]-ﬂuoro-L-m-tyrosine (FMT) positron
emission tomography (PET) uptake in striatal subregions was correlated with BMI (kg/m2) and an estimate of the frequency of
prior weight loss attempts in 15 healthy subjects. BMI was negatively correlated with FMT uptake in the dorsal caudate. Although
the association between BMI and FMT uptake in the dorsal caudate was not signiﬁcant upon correction for age and sex, the
association fell within the range of a statistical trend. Weight loss attempts divided by years trying was also negatively correlated
with FMT uptake in the dorsal putamen (P = .05). These results suggest an association between low dorsal striatal presynaptic
dopamine synthesis capacity and overeating behavior.
1.Introduction
Appetite regulation is complex and likely inﬂuenced by
activity of the midbrain dopaminergic system. Although the
hypothalamus integrates intestinal and hormonal signals to
regulate appetite and metabolism, the motivation to eat is
also regulated by activity of the midbrain dopamine system,
which processes cues related to the rewarding properties of
palatable food. In fact, hormones implicated in regulating
appetitive homeostasis also aﬀect dopamine brain dopamine
activity. For example, both leptin, which is released from
adipose tissue, and insulin, which is released from the pan-
creas following feeding, directly inhibit activity of dopamine
neurons projecting from ventral tegmental area (VTA) to
nucleus accumbens [1].
The striatum is a brain region well known for regulating
motivated behavior and is rich in dopaminergic axon ter-
minals. Dopaminergic projections from the midbrain (VTA
and substantia nigra) to the striatum are important in the
development and potentiation of conditioned reinforcement
and habitual appetitive responses in normal behavior and
addictive disorders. Aberrant activity in either dorsal or ven-
tral striatum has been reported to contribute to compulsive
motivatedbehaviorinthecaseofbothdrugandfoodseeking
[1, 2].
Evaluation of brain dopamine function is possible with
PET scanning and a number of radiotracers. The ligand 6-
[18F]-ﬂuoro-L-m-tyrosine (FMT) is a substrate of aromatic
amino acid decarboxylase (AADC), which converts levodopa
(L-DOPA) to dopamine. Because the metabolites of FMT,
6-[18F]ﬂuoro-3-hydroxyphenylacetic acid (FPAC) and 6-
[18F]ﬂuoro-3-hydroxyphenethylamine (FMA), are trapped
in dopaminergic terminals, FMT provides a method to
probe the capacity of nigrostriatal neurons to synthesize
dopamine. FMT is similar to 6-[18F]ﬂuorodopa (FDOPA),
in that both ligands are substrates of AADC. However,
unlike FDOPA, FMT lacks the catechol structure and is not
a substrate for the peripheral enzyme catechol-O-methyl-
transferase (COMT). Therefore, there are no metabolites
to contribute to radioactive background signal in the PET
image, improving signal to noise and simplifying kinetic
models [3].2 Journal of Obesity
Figure 1: MRI scan with superimposed FMT PET Ki images showing tracer uptake in caudate and putamen at two diﬀerent axial slices.
Human neuroimaging studies show that low D2 receptor
availability in the striatum is associated with high body mass
index (BMI) [4, 5]. The relationship between dopamine
synthesis capacity and BMI or overeating behavior has yet
to be explored and was the main purpose of this study.
2. Methods
This study was approved by the University of California
at Berkeley Committee for Protection of Human Subjects.
Sixteen healthy subjects were recruited through newspaper
advertisements and ﬂiers for a study on striatal FMT and
aging (age 20–30) [6]. Subjects for the aging study were
excluded if they had a history of major neurological disorder,
psychiatric disorder, eating disorder, systemic disease, or
head injury. Subjects were also excluded if they reported a
history of an alcohol or drug abuse problem, if they were
regular smokers, or if they drank more than 14 alcoholic
beverages per week for men and more than 7 for women.
Fifteen of the sixteen subjects in the aging study were willing
toanswerquestionsabouteatingbehaviorandwereincluded
in the analyses in this paper.
Before PET scanning, subjects received 2.5mg/kg oral
carbidopa, a peripheral decarboxylase inhibitor, to increase
the availability of FMT in plasma. Subjects were scanned on
a Siemens ECAT EXACT HR PET system in 3D acquisition
mode approximately 60 minutes (range 45–90 minutes) after
carbidopa administration. The instrument has a 3.6mm in-
plane voxel size and 47 parallel imaging planes. First, a
10-minute transmission scan was acquired. Approximately
2.5mCi (range 2.1–2.5mCi) of the radiotracer FMT were
injected, and immediately afterwards an 89-minute dynamic
scanwasacquired(4×1minutes,3×2minutes,3×3minutes,
14 ×5m i n u t e s ) .
Data were reconstructed using an ordered subset expec-
tation maximization algorithm with weighted attenuation,
an image size of 256 × 256, and 6 iterations with 16 subsets.
A Gaussian ﬁlter with 6mm FWHM was applied with
scattercorrection.Thepoint-spreadfunctionusedforpartial
volume correction (PVC) was evaluated from a phantom
that had been scanned and reconstructed using this speciﬁc
scanner. Images were evaluated for patient motion and
adequacy of statistical counts. Individual PET frames were
realigned using Statistical Parametric Mapping 2 (SPM2).
Magnetic resonance images (MRIs) were obtained using
a Varian Unity/Inova whole body 4.0T scanner (Palo
Alto, CA: http://www.varianinc.com/) with a TEM send-
and-receive head coil (MR Instruments, Minneapolis, MN;
http://www.mrinstruments.com/). MPFLASH T1-weighted
v o l u m e t r i cs c a n sw e r ea c q u i r e df o re a c hs u b j e c t( TR =
9msecond,TE = 4.8msecond,FOV = 22.4×22.4×19.8cm,
matrix size = 256×256×128,resolution = 0.875×0.875×
1.54mm). MRI images were processed by using the Auto-
matic Segmentation Tool (FAST) from version 3.3 of Oxford
Centre for Functional MRI of the Brain “(FMRIB) Software
Library” (FSL). Nonlinear noise was then reduced using
FSL “Smallest Univalue Segment Assimilating Nucleus”
(SUSAN). A mask of MRI scan intracranial matter was
automatically generated using FSL “Brain Extraction Tool”
(BET). Individual intracranial masks were manually reﬁned
using “FSL view”. FSL FAST was used to segment the skull-
stripped brains into brain matter versus CSF. A binary mask
of the brain matter alone was created for use in partial
volume correction of the PET data. (For more details about
MRI methods and related references please see Braskie et al.,
2008 [6].)
Regions of interest (ROIs) (dorsal caudate, dorsal puta-
men, and ventral striatum) were hand drawn on MRI images
using “FSL view”. We used preestablished guidelines with
some modiﬁcation: for ventral striatum we excluded the
most posterior 25% of slices on which we had segmented
caudate to avoid inclusion of the basal nucleus of Meynert
[7]. Good interrater reliability was established on ﬁve left
ROIs for dorsal caudate (ICC = 0.996), dorsal putamen
(ICC = 0.993), and ventral striatum (ICC = 0.967).
MRI images were realigned to summed PET images
using SPM2 (Figure 1). Voxelwise Ki values (1/min) were
calculated using a graphical analysis for irreversible binding
[8]. This approach produces Ki images that are scaled
to the volume of distribution of FMT in the reference
region and is therefore independent of subject weight and
body composition. We used cerebellar grey matter as a
reference region. Cerebellar masks were drawn in MRI
native space on coronal images and comprised two thirds
of the slices posterior to the last slice in which the superior
cerebellarpedunclesstretchedsuperiorly.FSLFASTwasused
to segment and exclude major white matter tracts in the
cerebellum. Scaled Ki images were created from PET frames
corresponding to 24 through 89 minutes.Journal of Obesity 3
Table 1: Spearman Correlation Coeﬃcients for FMT Uptake versus
BMI (kg/m2) and versus Weight Loss Attempts/Years Trying.
BMI (kg/m2) Weight loss
Attempts/Years Trying
Region of interest rho P rho P
Dorsal caudate −0.77 .001 −0.37 .17
Dorsal putamen −0.39 .16 −0.55 .05
Ventral striatum −0.13 .65 −0.34 .21
At brain/nonbrain boundaries, partial volume errors
o c c u r ,a n ds u b j e c t sw i t hm o r eb r a i na t r o p h y ,o rm o r e
extensive brain/cerebrospinal ﬂuid boundaries, will have
more apparent PET signal attenuation. This is due to the
inherent limitations in spatial resolution of the PET scanner.
Although brain atrophy is not typically a concern in younger
adults, developmental changes in brain structure render
partial volume eﬀects important even in young subjects [9].
To improve the comparability of our measurements across
subjects, partial volume correction (PVC) was applied to all
our Ki images using a two-compartment method [10]. In
this method, the binary mask created from the MRI brain
images was convolved with the PET point spread function.
The corrected PET value was estimated as the observed PET
scan signal divided by the convolved brain matter mask.
Partial volume-corrected Ki values (1/minute) are referred to
as either “FMT uptake” or “Ki”.
All ﬁfteen subjects ﬁlled out a Binge Eating Scale (BES)
[11] questionnaire and were asked about number of weight
loss attempts in their lives and the number of years they had
been trying to lose weight. Reported weight loss attempts
were divided by number of years they had been trying, to
represent an estimate of the frequency of prior weight loss
attempts. Body mass index (BMI) (kg/m2) was obtained on
all subjects on the day of their scan.
Because FMT uptake, BMI, and Weight Loss
Attempts/Years Trying values were not normally distributed,
we used the nonparametric Spearman (rho) correlation
coeﬃcient. We averaged left and right hemisphere ROIs
because we did not have hypotheses about the unilateral
regions of interest, because the regions were correlated with
oneanother,andbecausewewantedtoreducethenumberof
variables. In this paper, we refer to the averaged left and right
hemisphere ROIs as either the ventral striatum, the dorsal
putamen, or the dorsal caudate. We used partial Spearman
correlation to assess the relationship between FMT uptake
and BMI, while controlling for both age and sex [12].
3. Results
Six men and nine women participated in this study. The
mean age was 22.9 years and the mean BMI was 25.3. Three
subjects had BMI > 30kg/m2; three subjects had BMI
between 25kg/m2 and 30kg/m2.B M Iw a sn e g a t i v e l yc o r r e -
lated with dorsal caudate FMT uptake (Table 1, Figure 2).
Weight Loss Attempts/Years Trying and dorsal putamen
FMT uptake were negatively correlated (P = .05) (Table 1,
18
20
22
24
B
M
I
(
k
g
/
m
2
)
26
28
30
32
34
0.015 0.016 0.017
FMT uptake in dorsal caudate (1/min)
0.018 0.019 0.02 0.021 0.022
Figure 2: Relationship between body mass index (BMI, kg/m2)
and FMT uptake in the dorsal caudate averaged over left and right
hemispheres in 15 young healthy individuals. FMT uptake reﬂects
dopamine synthesis capacity and is measured as partial volume
corrected inﬂux constant, or Ki in 1/min.
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Figure 3: Relationship between Weight Loss Attempts/Years Trying
and FMT uptake in the dorsal putamen averaged over the left
and right hemispheres in 15 young healthy individuals. Weight
Loss Attempts/Years Trying reﬂects an estimate of the frequency
of prior weight loss attempts. FMT uptake reﬂects dopamine
synthesis capacity and is measured as partial volume corrected
inﬂux constant, or Ki in 1/minute.
Figure 3). Only one subject scored in the pathological range
(>17) on the BES [13], and this scale was dropped.
Previous studies have found an association between sex
and FDOPA uptake [14]. In our sample, men and women
diﬀered in FMT uptake in the caudate using a two sample t-
test assuming unequal variances (P<. 05, two tailed), with
a mean FMT uptake of.0194 for women, and.0175 for men.
TherewasnotasigniﬁcanteﬀectofsexonFMTuptakeinthe
dorsal putamen or ventral striatum (rho < |0.4|, P>. 15).
We also examined the relationship between FMT uptake
and age (years), as previous studies have found a signiﬁcant
relationship between FMT and age [6]. In dorsal caudate,
there was a signiﬁcant correlation between FMT uptake and
age (rho =− 0.81, P = .0002). In the other regions, there
werenosigniﬁcantcorrelationsbetweenageandFMTuptake
(rho < |0.4|, p>. 15).
To conﬁrm that neither age nor sex was confounding
our results, we reexamined the relationship between dorsal
caudate FMT uptake and BMI after adjusting for age alone4 Journal of Obesity
and sex alone. The corrected relationship between dorsal
caudate FMT uptake and BMI was still signiﬁcant (P = .02
after adjusting for age, P = .005 after adjusting for sex).
When we examined this relationship adjusting for both age
and sex using partial Spearman correlations, we found that
the correlation was no longer signiﬁcant but fell within
the range of a statistical trend (P = .07). In addition,
when examining males and females separately, the Spearman
correlation coeﬃcients for the dorsal caudate FMT uptake
versus BMI relationship were −0.49 and −0.48 respectively.
We did not correct for age and sex for the association
between Weight Loss Attempts/Years Trying and dorsal
putamen Ki because age and sex were not signiﬁcantly
correlated with either variable (rho < |0.4|, P>. 15).
4. Discussion
These data suggest that there is an association between low
dorsal striatal dopamine synthesis capacity and overeating
behavior. With correction for both of the potential con-
founding eﬀects of age and sex, the correlation between BMI
and dorsal caudate FMT uptake was not signiﬁcant but fell
within the range of a statistical trend. In addition, the similar
correlation coeﬃcients between FMT uptake and BMI in
dorsal caudate for males and females support the notion that
these eﬀects are related to BMI rather than sex. Finally, there
wasanegativecorrelationbetweenagreaterfrequencyofpast
dieting attempts and dorsal putamen FMT.
One possible explanation of our ﬁndings is that overeat-
ing behavior, as indicated by high BMI and higher frequency
ofweightlossattempts,maydownregulatedopaminesynthe-
sis,asindicated byFMTuptake.Previousstudieshaveshown
that AADC upregulates in response to D1 and D2 receptor
antagonist administration [15]. Binge sucrose ingestion
and food consumption are known to be associated with
dopamine release in the striatum [16, 17]. Increased synaptic
dopamine could theoretically downregulate striatal AADC
activityandFMTuptake.However,bingesugarconsumption
has been shown to result in a decrease in D2 receptor density
in the dorsal striatum [18]. Such receptor downregulation
would be expected to increase AADC activity [15]a n dr e s u l t
i nh i g h e rF M Tu p t a k e .T h u s ,i ti sd i ﬃcult to explain our
ﬁndings from this perspective alone.
Another possible explanation is that hormones might
contribute to the association between overeating behavior
and FMT uptake. Evidence suggests that insulin and leptin,
hormonesreleasedafteringestionoffood,bothcurbappetite
and inhibit dopaminergic VTA neurons [1]. Ghrelin, in
contrast, which is released by the stomach as a hunger signal,
seems to have a stimulatory eﬀect on VTA dopaminergic
neurons [1]. The low FMT uptake in higher weight subjects
could simply be related to higher circulating leptin and
insulin and lower ghrelin.
Previous studies suggest an overlap between addictive
disorders and overeating disorders. Sugar and drugs of
abuse can have similar eﬀects on striatal dopamine release
and behavior in animal behavioral models [16]. Obese
individuals and individuals with Binge Eating Disorder
may have similarly impulsive neuropsychological proﬁles
when compared to individuals with addictive disorders [19].
Finally, a low D2 receptor density is also associated with
a both higher risk of addictive behavior and overeating
behavior [20, 21].
FDOPA and FMT are measures of presynaptic dopamine
synthesis capacity while the PET tracer [11C]raclopride is a
ligand for the D2 receptor. At least four past studies have
examined the association between presynaptic dopamine
synthesis capacity or dopamine transmission and another
form of addictive behavior—severity of alcohol dependence.
Consistent with our data, two of these found a negative
association between FDOPA uptake and alcohol dependence
severity [22, 23]. Another study found a negative associa-
tion between raclopride displacement in the striatum after
stimulant administration (indicating decreased dopamine
release) and alcohol dependence [20]. These studies support
the notion that there is a low presynaptic dopamine syn-
thesis capacity in subjects with higher severity of addictive
behavior. By contrast, only one study showed increased
FDOPA uptake in the left putamen and right caudate in
alcoholics compared to controls, and this was a study of type
Ialcoholics,asubtypewhichmaydistinguishthispopulation
from some of the other studies [2].
Given the similarity between our ﬁndings and the
majority of the ﬁndings of those studies of alcoholic subjects,
the association we found in this study between BMI and
the estimate of the frequency of prior weight loss attempts
and striatal FMT uptake could imply that low presynaptic
dopamine synthesis capacity in the dorsal striatum is a
marker for poor decision-making and diﬃculty controlling
food intake in response to food cues. Increased craving
and food cue presentation are associated with increased
fMRI activation and dopamine release in the dorsal striatum
[24, 25]. Obesity is also associated with increased dorsal
striatal fMRI activation in response to food cues [26]. The
dopamine-rich dorsal striatum is critical for the regulation
of feeding and addictive behavior and plays an integral
role in the habitual or “stimulus-response” component of
motivated behavior [1, 27, 28]. In other words, dopamine
mediatestheabilityforenvironmentalcuestotriggerlearned
responses that were previously associated with reward [27,
28]. A dopamine imbalance in the dorsal striatum could
predispose to diﬃculty controlling impulses when exposed
to a cue in the environment associated with food reward. A
recent study showed that three DRD3 genotypes predicted
ADHDsymptoms,whichinturnwasassociatedwithahigher
rate of obesity and binge eating symptoms, supporting this
hypothetical link between dopaminergic dysfunction and
impulsivity in overeaters [29].
Finally, our ﬁndings could also indicate that subjects
with lower FMT uptake in the dorsal striatum have a
greater predisposition to overeat as a result of decreased
baseline activation of reward circuitry. Increased fMRI acti-
vation, increased regional cerebral blood ﬂow, and increased
dopamine release in the dorsal striatum are associated with
food administration but appear to decrease as motivation
to eat decreases [17, 30, 31]. Moreover, the amount of
dopamine released in the dorsal striatum correlates with theJournal of Obesity 5
degree of experienced pleasure [17]. These studies implicate
dorsal striatal dopamine as a mediator of food reward and
satiety. Other studies in humans have shown decreased
D2 density in the dorsal striatum in obese individuals
and hypothesize that low brain dopamine activity leads to
overeating in order to compensate for decreased activation
of reward circuits [4, 5, 32]. Lower presynaptic dopamine
synthesis capacity in the dorsal striatum could similarly
predispose an individual to use excessive food in order to
stimulateunderactiverewardcircuitryandtoachievesatiety.
This study was somewhat limited by a relatively small
sample size and a narrow range of overeating pathology
whichmakesitdiﬃculttofullyexamineinteractionsbetween
dopamine synthesis, overeating, age and sex. Only one sub-
ject scored in the pathological range on the BES. Moreover,
a partial correlation correcting for two variables with this
sample size may have masked true ﬁndings. However, one
m i g h ta r g u et h a tc o r r e c t i n gf o ra g ea n ds e xm a yb et o o
conservative and that BMI may be driving the association
between FMT and age or sex, not the other way around.
Unadjusted ﬁndings were quite strong and still in the range
of a trend after adjustment for these potential confounders.
These results, along with similar ﬁndings using other PET
approaches in obesity, and similar ﬁndings on the role of
dopamine in addictive disorders, suggest a role for dopamine
in these behaviors. The association of presynaptic dopamine
synthesis capacity with overeating behavior deserves further
investigation.
5. Conclusion
Inthisstudy,highBMIanddiﬃcultycontrollingweightwere
associated with low dorsal striatal FMT uptake, reﬂective
of low dopamine synthesis capacity. These data support
the hypothesis that changes in striatal dopamine synthesis
are associated with changes in weight and appetitive drive
and support other data indicating that striatal dopamine
metabolism plays a role in the motivational aspects of food
seeking behavior.
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